Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score N/A
- Piotroski Score 2.00
- Grade Buy
- Symbol (OKYO)
- Company OKYO Pharma Limited
- Price $1.07
- Changes Percentage (0.94%)
- Change $0.01
- Day Low $1.03
- Day High $1.09
- Year High $2.30
OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead product includes OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/29/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.61
- Trailing P/E Ratio -2.08
- Forward P/E Ratio -2.08
- P/E Growth -2.08
- Net Income $-16,825,461
Income Statement
Quarterly
Annual
Latest News of OKYO
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Tokyo shares fall, Hong Kong's advance as tensions escalate in the Middle East
Asian markets were mixed as Tokyo fell while Hong Kong rose despite tensions in the Middle East. Oil prices surged after Iran's missile attack on Israel. U.S. job openings unexpectedly rose, but thin ...
By Yahoo! Finance | 3 days ago -
Tokyo Game Show 2024: Surprisingly Chaotic And Fun
The Tokyo Game Show this year showcased a return to form with a focus on various games, reflecting a shift towards Asian game development....
By Forbes | 1 week ago -
Subway operator Tokyo Metro launches $2.25 billion IPO
TOKYO (Reuters) -Subway operator Tokyo Metro said on Friday it plans to list on the Tokyo Stock Exchange on Oct. 23, setting the stage for what would be Japan's largest initial public offering (IPO) i...
By Reuters | 2 weeks ago